Žemaitijos vet. vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 452,120 | 535,022 | 607,052 | 724,769 | 781,109 | 855,047 | 871,057 | 729,157 |
| Profit before tax | 4,097 | 5,780 | 9,667 | 16,015 | 9,039 | 14,325 | 14,901 | 9,745 |
| Net profit | 3,443 | 4,903 | 8,160 | 13,613 | 7,682 | 12,174 | 12,666 | 8,177 |
| Equity | 61,713 | 66,616 | 74,776 | 88,389 | 96,071 | 96,072 | 108,738 | 116,915 |
| Liabilities | 74,018 | 74,290 | 88,504 | 81,501 | 127,417 | 127,416 | 108,539 | 140,627 |
| Non-current assets | 4,647 | 4,106 | 5,014 | 3,824 | 1,991 | 1,991 | 54 | 54 |
| Current assets | 131,084 | 136,800 | 158,266 | 166,066 | 221,497 | 221,497 | 217,223 | 257,488 |
| Total assets | 135,731 | 140,906 | 163,280 | 169,890 | 223,488 | 223,488 | 217,277 | 257,542 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 83,907 | 89,053 | 90,363 |
| Social insurance contributions | - | - | - | - | - | 43,374 | 51,061 | 64,515 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +16.0% | +18.3% | +13.5% | +19.4% | +7.8% | +9.5% | +1.9% | -16.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.5% | 3.5% | 5.0% | 8.0% | 3.4% | 5.4% | 5.8% | 3.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 5.6% | 7.4% | 10.9% | 15.4% | 8.0% | 12.7% | 11.6% | 7.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.8% | 0.9% | 1.3% | 1.9% | 1.0% | 1.4% | 1.5% | 1.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.9% | 1.1% | 1.6% | 2.2% | 1.2% | 1.7% | 1.7% | 1.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.2 | 1.1 | 1.2 | 0.9 | 1.3 | 1.3 | 1.0 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 30,310 | 32,757 | 38,955 | 51,769 | 49,333 | 61,811 | 64,127 | 52,083 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Žemaitijos vet. vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-26 | 2026-07-28 | 794.61 |
| 2026-02-20 | 2026-03-03 | 45.19 |
| 2026-02-19 | 2026-02-19 | 5335.01 |
| 2026-01-21 | 2026-02-18 | 2.64 |
| 2025-12-16 | 2025-12-29 | 19.82 |
| 2024-10-28 | 2024-11-14 | 7.48 |
| 2024-10-24 | 2024-10-27 | 6.69 |
| 2024-09-17 | 2024-09-25 | 242.96 |
| 2024-08-19 | 2024-08-20 | 4461.10 |
| 2024-07-24 | 2024-08-18 | 18.06 |
| 2024-07-16 | 2024-07-23 | 16.86 |
| 2024-06-18 | 2024-06-20 | 83.81 |
| 2023-11-16 | 2023-11-21 | 187.83 |
| 2023-08-17 | 2023-09-14 | 1.53 |
| 2023-08-07 | 2023-08-13 | 1.53 |
| 2023-07-26 | 2023-07-27 | 1.06 |
| 2023-07-24 | 2023-07-25 | 1.10 |
| 2022-04-25 | 2022-04-26 | 8.58 |
| 2022-02-17 | 2022-02-24 | 3033.71 |
| 2021-11-16 | 2021-11-22 | 21.06 |
Žemaitijos vet. vaistinė - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Žemaitijos vet. vaistinė is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 0.01 |
| 2026-08-28 | 2026-08-31 | 71.48 |
| 2026-08-25 | 2026-08-25 | 71.47 |
| 2026-08-20 | 2026-08-24 | 71.42 |
| 2026-08-19 | 2026-08-19 | 37.28 |
| 2026-07-29 | 2026-08-13 | 9.12 |
| 2026-06-05 | 2026-06-05 | 1435.27 |
| 2026-05-22 | 2026-05-25 | 34.25 |
| 2026-05-07 | 2026-05-17 | 6.45 |
| 2026-05-01 | 2026-05-06 | 24.53 |
| 2026-04-30 | 2026-04-30 | 23.22 |
| 2026-04-28 | 2026-04-29 | 5.14 |
| 2026-03-27 | 2026-04-01 | 9.58 |
| 2026-03-20 | 2026-03-26 | 2.51 |
| 2026-03-18 | 2026-03-19 | 1.34 |
| 2026-03-08 | 2026-03-11 | 490.32 |
| 2026-03-02 | 2026-03-07 | 3152.58 |
| 2026-02-27 | 2026-03-01 | 3235.32 |
| 2026-01-29 | 2026-02-16 | 15.35 |
| 2025-08-31 | 2025-09-01 | 2.1 |
| 2025-08-30 | 2025-08-30 | 4.32 |
| 2025-08-22 | 2025-08-29 | 1000.9 |
| 2025-08-07 | 2025-08-07 | 26.1 |
| 2025-08-01 | 2025-08-06 | 26.04 |
| 2025-07-23 | 2025-07-30 | 17.4 |
| 2025-07-17 | 2025-07-22 | 2168.54 |
| 2025-07-16 | 2025-07-16 | 2151.0 |
| 2025-07-11 | 2025-07-15 | 2168.37 |
| 2025-07-02 | 2025-07-10 | 17.37 |
| 2025-07-01 | 2025-07-01 | 518.64 |
| 2025-06-30 | 2025-06-30 | 511.82 |
| 2025-06-19 | 2025-06-29 | 506.27 |
| 2025-03-26 | 2025-03-26 | 0.31 |
| 2025-03-20 | 2025-03-25 | 167.64 |
| 2025-03-19 | 2025-03-19 | 167.49 |
| 2025-03-17 | 2025-03-18 | 167.41 |
| 2025-03-09 | 2025-03-16 | 131.73 |
| 2025-03-08 | 2025-03-08 | 131.52 |
| 2025-03-07 | 2025-03-07 | 127.69 |
| 2025-02-20 | 2025-02-25 | 38.64 |
| 2025-02-18 | 2025-02-18 | 38.64 |
| 2025-02-17 | 2025-02-17 | 3.35 |
| 2025-01-30 | 2025-02-16 | 5.93 |
| 2025-01-29 | 2025-01-29 | 4.26 |
| 2025-01-17 | 2025-01-28 | 452.28 |
| 2025-01-01 | 2025-01-16 | 4.8 |
| 2024-12-18 | 2024-12-30 | 0.49 |
| 2024-12-17 | 2024-12-17 | 137.65 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Žemaitijos vet. vaistine, UAB (code 303215363) is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In 2025, the company generated revenue of €729.2K and net profit of €8.2K, corresponding to a profit margin of 1.1%. Revenue declined by 16.3% year on year and was 14.7% lower than two years earlier, after reaching €855.0K in 2023 and €871.1K in 2024. Net profit followed a similar pattern, moving from €12.2K in 2023 to €12.7K in 2024 and then to €8.2K in 2025. At year-end 2025, total assets stood at €257.5K, equity at €116.9K and liabilities at €140.6K. The company’s equity ratio was 45.4%, debt-to-equity was 1.20, ROE was 7.0% and ROA was 3.2%. Asset turnover reached 2.83x, indicating efficient use of assets relative to revenue. Productivity was moderate, with revenue per employee of €52.1K and profit per employee of €584 in 2025.